Buy & Sell TG Therapeutics Inc (TGTX) – TG Therapeutics Inc Price Today
Aura AI Summary
Key Stats
- $5.81BMarket Cap
- HealthSector
- -12.35%3M Drawdown
- $6.05BEnterprise Value
- -Dividend Yield
- 9 daysTypical Hold Time
TG Therapeutics Inc (TGTX) is currently valued at a market capitalization of $5.81B, with an enterprise value of $6.05B. Over the past 52 weeks, TG Therapeutics Inc has traded between a low of $26.39 and a high of $43.14, highlighting its annual price range. Over the past three months, TG Therapeutics Inc has recorded a drawdown of -12.35%, reflecting recent price volatility. On average, investors hold TG Therapeutics Inc for approximately 9 days, indicating typical investor behavior on the platform.
About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Most Recent News
Stock and oil futures open as Iran war enters fourth month with no resolution.
Stock and oil futures began trading as the conflict in Iran entered its fourth month without any signs of resolution. The ongoing war continues to influence market sentiment and commodity prices, keeping investors cautious. Traders will be watching f...

CAPHRA urges full stakeholder inclusion in Asia Pacific tobacco control policies for better public health outcomes.
The Coalition of Asia Pacific Harm Reduction Advocates (CAPHRA) released a position paper calling for formal inclusion of all key stakeholders in tobacco control policy-making across the Asia Pacific. They argue that policies made without meaningful ...

Diana Shipping pushes to replace Genco's board with six independent nominees amid takeover bid.
Diana Shipping, the largest shareholder of Genco Shipping & Trading, has sent an open letter urging Genco shareholders to elect six independent director nominees at the upcoming annual meeting. Diana criticizes the current Genco board for prioritizin...
